| JASPAR 2010: the greatly expanded open-access database of transcription factor binding profiles E Portales-Casamar, S Thongjuea, AT Kwon, D Arenillas, X Zhao, ... Nucleic acids research 38 (suppl_1), D105-D110, 2010 | 733 | 2010 |
| The transcription factor encyclopedia D Yusuf, SL Butland, MI Swanson, E Bolotin, A Ticoll, WA Cheung, ... Genome biology 13, 1-25, 2012 | 128 | 2012 |
| Highly selective SGLT2 inhibitor dapagliflozin reduces seizure activity in pentylenetetrazol-induced murine model of epilepsy MA Erdogan, D Yusuf, J Christy, V Solmaz, A Erdogan, E Taskiran, ... BMC neurology 18, 1-8, 2018 | 46 | 2018 |
| Outcomes of patients with relapsed or refractory acute myeloid leukemia: a population-based real-world study JM Brandwein, L Saini, MN Geddes, D Yusuf, F Liu, K Schwann, ... American Journal of Blood Research 10 (4), 124, 2020 | 23 | 2020 |
| Population-based Treatment Patterns and Outcomes for Stage III Non–Small Cell Lung Cancer Patients: A Real-world Evidence Study D Yusuf, RN Walton, M Hurry, C Farrer, DG Bebb, WY Cheung American journal of clinical oncology 43 (9), 615-620, 2020 | 15 | 2020 |
| Gene characterization index: assessing the depth of gene annotation D Kemmer, RM Podowski, D Yusuf, J Brumm, W Cheung, C Wahlestedt, ... PLoS One 3 (1), e1440, 2008 | 15 | 2008 |
| Predictive and prognostic properties of human equilibrative nucleoside transporter 1 expression in gemcitabine-treated pancreatobiliary cancer: a meta-analysis LJ Vos, D Yusuf, A Lui, Z Abdelaziz, S Ghosh, JL Spratlin, JR Mackey JCO Precision Oncology 3, 1-22, 2019 | 12 | 2019 |
| Levodropropizine suppresses seizure activity in rats with pentylenetetrazol-induced epilepsy MA Erdogan, D Yusuf, A Erdogan, O Erbas Epilepsy Research 150, 32-37, 2019 | 10 | 2019 |
| A case report of nifedipine-induced hepatitis with jaundice D Yusuf, J Christy, D Owen, M Ho, D Li, MJ Fishman BMC Research Notes 11, 1-9, 2018 | 10 | 2018 |
| A population-based retrospective study of biliary tract cancers in Alberta, Canada C Beaulieu, A Lui, D Yusuf, Z Abdelaziz, B Randolph, E Batuyong, ... Current Oncology 28 (1), 417-427, 2021 | 8 | 2021 |
| The Gene Set Builder: collation, curation, and distribution of sets of genes D Yusuf, JS Lim, WW Wasserman BMC bioinformatics 6, 1-5, 2005 | 7 | 2005 |
| Development of a model for predicting early discontinuation of adjuvant chemotherapy in stage III colon cancer DJ Boyne, DR Brenner, TT Sajobi, RJ Hilsden, D Yusuf, Y Xu, ... JCO Clinical Cancer Informatics 4, 972-984, 2020 | 5 | 2020 |
| A Population-based Study of Treatment Patterns and Survival of Patients With De Novo Stage IV Non–Small Cell Lung Cancer A Batra, D Yusuf, M Hurry, RN Walton, N Devost, C Farrer, WY Cheung American Journal of Clinical Oncology 44 (10), 512-518, 2021 | 1 | 2021 |
| Real-world outcomes for metastatic non-small cell lung cancer patients treated with checkpoint inhibitor immunotherapy in Canada. D Yusuf, JJ Ko, H Cho, C Sheremeto, Y Wang, RA Juergens, PM Ellis, ... Journal of Clinical Oncology 38 (5_suppl), 54-54, 2020 | 1 | 2020 |
| Predictive value of hENT1 immunohistochemistry for gemcitabine-treated pancreatic cancer is antibody dependent. D Yusuf, A Lui, Z Abdelaziz, JL Spratlin, JR Mackey Journal of Clinical Oncology 35 (15_suppl), e15746-e15746, 2017 | 1 | 2017 |
| Oncopre: A new chemotherapy benefit prediction algorithm to assist treatment decision making. D Yusuf, MY Ho, HF Kennecke, WY Cheung Journal of Clinical Oncology 35 (4_suppl), 705-705, 2017 | 1 | 2017 |
| PS1043 OUTCOMES OF PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA: A POPULATION-BASED REAL-WORLD STUDY L Saini, MN Geddes, FF Liu, D Yusuf, K Schwann, A Billawala, C Westcott, ... HemaSphere 3 (S1), 471-472, 2019 | | 2019 |
| A retrospective, real-world population-based analysis of treatment patterns and outcomes in adult patients with relapsed/refractory acute myeloid leukemia in Alberta, Canada. MN Geddes, L Saini, FF Liu, D Yusuf, K Schwann, A Billawala, ... Journal of Clinical Oncology 37 (15_suppl), e18505-e18505, 2019 | | 2019 |
| P3. 15-30 Treatment Patterns and Survival of Patients with Stage IV Non-Small Cell Lung Cancer (NSCLC) in the Era of Novel Therapies D Yusuf, M Hurry, R Walton, W Cheung Journal of Thoracic Oncology 13 (10), S1002, 2018 | | 2018 |
| P1. 15-34 Treatment Patterns and Outcomes of Stage III Non-Small Cell Lung Cancer (NSCLC): Real World Evidence of How our Patients Fare D Yusuf, R Walton, M Hurry, W Cheung Journal of Thoracic Oncology 13 (10), S626, 2018 | | 2018 |
Wyeth WassermanProfessor of Medical Genetics, University of British ColumbiaVerified email at cmmt.ubc.ca
